Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha
about
Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response.IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.An update on epidermal growth factor receptor inhibitors.ZD1839 (IRESSA): a selective EGFR-TK inhibitor.Advances in monoclonal antibody technology: genetic engineering of mice, cells, and immunoglobulins.Molecular therapy in head and neck oncology.EGFR(s) in aging and carcinogenesis of the gastrointestinal tract.Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptorExpression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin.Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.Recombinant toxins in haematologic malignancies and solid tumours.
P2860
Q33591326-68590D73-7158-4A1E-9091-C54DCD828C4EQ34451934-CAB530A6-CFD5-4BC1-A99C-9D9A15908B1EQ34457436-7C179EDF-F4ED-444B-A543-2379ED0B394FQ34734513-71EE98FB-12E5-40A1-9FBF-D518F069DB99Q36161922-8BC88599-D62E-425C-96C3-AAD308EE5F40Q37458175-E236E62B-3A5E-48AE-8C7B-647B77CAA101Q37552436-226EA984-DD42-4C78-8A25-92E79323C0A7Q38020872-DF3595CB-B975-4BB4-8BE7-9C98FBB9AB24Q41911341-9DF1D9D1-5B6F-4B69-B007-1343983C9825Q42831914-5A374A9A-38D3-4222-A3AE-DFF4C7DD46D8Q43844110-261BA0A6-5007-4705-903F-0AF1A18228D5Q47808995-C186CC29-545E-4B72-BBDB-0B38660E07DCQ53668245-05C7E95F-D81D-4CED-BA13-329881FB35A7
P2860
Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Targeted inhibition of tumour ...... antibody domain and TGF alpha
@en
Targeted inhibition of tumour ...... antibody domain and TGF alpha.
@nl
type
label
Targeted inhibition of tumour ...... antibody domain and TGF alpha
@en
Targeted inhibition of tumour ...... antibody domain and TGF alpha.
@nl
prefLabel
Targeted inhibition of tumour ...... antibody domain and TGF alpha
@en
Targeted inhibition of tumour ...... antibody domain and TGF alpha.
@nl
P2860
P356
P1476
Targeted inhibition of tumour ...... antibody domain and TGF alpha
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.448
P407
P577
1996-09-01T00:00:00Z
P5875
P6179
1022232130